Evidence map›Paper›PMID 41048662›Full record

ArticleEClinicalMedicine2025

Tackling healthcare providers bias: a systematic review of interventions with implications for inclusive clinical research.

Maria Grammoustianou, Stefano Maccarone, Emma Gillanders, Gwenn Menvielle, Marie Preau, Stepheline Ginguene, Sibille Everhard, Cyrille Delpierre, Francis Guillemin, Ines Vaz-Luis and 1 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Current controversies in acromegaly care.The Journal of clinical endocrinology and metabolism · 2026
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Maria GrammoustianouBreast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Stefano MaccaroneBreast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Emma GillandersBreast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Gwenn MenvielleBreast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Marie PreauInserm U1296, Radiations: Santé, Défense, Environnement (Radiation: Health, Defense, Environment), University Lumière Lyon 2, France.
Stepheline GingueneInserm U1296, Radiations: Santé, Défense, Environnement (Radiation: Health, Defense, Environment), University Lumière Lyon 2, France.
Sibille EverhardUNICANCER, Direction des Data et des Partenariats, Le Kremlin-Bicêtre, France.
Cyrille DelpierreCERPOP, Université Toulouse III-Paul Sabatier, Toulouse, France.
Francis GuilleminCHRU-Nancy, Inserm, Université de Lorraine, CIC, Epidémiologie Clinique, 54000, Nancy, France.
Ines Vaz-LuisBreast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.
Maria Alice FranzoiBreast Cancer Survivorship Group, INSERM Unit 981, Gustave Roussy, Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Diverse population inclusion in clinical research is essential for generating high-quality, generalizable data that promotes health equity. However, clinical research often underrepresents elderly individuals, minoritised ethnicities, and marginalized socio-demographic groups. Implicit and explicit biases among healthcare providers can create barriers to equitable participation in clinical trials, affecting patient care, clinical outcomes, and provider-patient trust. Bias-focused interventions have been reported, yet methodological inconsistencies and limited generalizability of studies hinder their effectiveness. This systematic review synthesizes global evidence on interventions designed to address healthcare provider biases, identifying intervention components, trends, outcomes assessed and gaps in the current literature. Methods: Following PRISMA guidelines, a systematic review of English-language peer-reviewed studies published between 2004 and June 2025 was conducted. The review included both quantitative and qualitative studies assessing interventions targeting healthcare provider biases or cultural competency. A comprehensive search of Scopus, Cochrane, and PubMed MEDLINE databases identified 110 studies. Study quality, risk of bias, and outcomes were assessed using the RoB-2 tool for randomized trials and ROBINS-I for non-randomized studies (PROSPERO ID: CRD42024515985). Findings: Among the 103 studies assessed for efficacy, 75.7% reported positive outcomes. The majority of studies (69%) were conducted in the U.S. Most interventions combined educational and experiential methods, with the majority being brief (up to 3 h). An increase in the use of digital delivery methods was observed in the past 5 years, with 45% of studies incorporating digital components, particularly after 2020. Key outcomes included explicit bias (53.6%), cultural competency (31.2%), and implicit bias (31.8%), measured mainly by heterogeneous and non-standardized instruments. Notably, only 38 studies (34.5%) assessed actual healthcare provider behavior, and 30 studies (27.2%) evaluated long-term efficacy. High risk of bias and methodological challenges impacted the quality of evidence. Interpretation: This review highlights positive short-term effects of interventions on implicit bias and cultural competence but suggests future research could benefit from more rigorous trial designs, standardized metrics for measuring efficacy, and actual provider behavior. It also emphasizes the need for more implementation research to identify barriers and facilitators for scaling interventions to ensure their sustainability and broader impact on diversity, equity, and inclusion in healthcare and research. Funding: This project is funded by WeShare,DIVERSIFY and SIRIC Epicure projects. WeShare program is supported by the French State, managed by the Agence Nationale de la Recherche under the Investissements Program integrated into France 2030, with reference number: ANR-21-ESRE-0017. DIVERSIFY is funded by La Ligue Contre le Cancer. SIRIC Epicure is funded by INCA-DGOS-Inserm-ITMO Cancer 18002.

Indexed as

Clinical trialsCultural competenceDigitalDisparitiesExplicit biasHealthcareHealthcare providersImplicit biasInterventions

Identifiers

PMID41048662
PMCPMC12495421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.